These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A consistent model of insulin-dependent diabetes mellitus hypertension. Chen S; Yuan C; Schooley JF; Haddy FJ; Pamnani MB Am J Hypertens; 1992 Oct; 5(10):671-80. PubMed ID: 1418828 [TBL] [Abstract][Full Text] [Related]
7. Role of digitalis-like substance in the hypertension of streptozotocin-induced diabetes and simulated weightlessness in rats. Pamnani MB; Chen S; Haddy FJ; Yuan C; Mo Z Clin Exp Hypertens; 1998; 20(5-6):509-21. PubMed ID: 9682907 [TBL] [Abstract][Full Text] [Related]
8. The pathophysiological role of digitalis-like substance in essential hypertension. Saitoh S; Shimamoto K; Nakagawa M; Yamaguchi Y; Matsuda K; Kuroda S; Ura N; Iimura O J Hypertens Suppl; 1988 Dec; 6(4):S360-2. PubMed ID: 2853746 [TBL] [Abstract][Full Text] [Related]
12. Elevated endogenous digitalis-like substance in hypertensive diabetic patients with a family history of hypertension. Okamoto S; Ikeda M; Morise T; Miyamori I; Takeda R J Endocrinol Invest; 1991 May; 14(5):357-60. PubMed ID: 1651964 [TBL] [Abstract][Full Text] [Related]
13. [Endogenous digitalis-like substance and Na-K-ATPase inhibitor in cardiovascular and renal disease]. Okamoto S Nihon Naibunpi Gakkai Zasshi; 1988 Jan; 64(1):39-50. PubMed ID: 2837414 [TBL] [Abstract][Full Text] [Related]
14. Antihypertensive effect of canrenone in a model where endogenous ouabain-like factors are present. de Mendonça M; Grichois ML; Pernollet MG; Wauquier I; Trouillet-Thormann B; Meyer P; Devynck MA; Garay R J Cardiovasc Pharmacol; 1988 Jan; 11(1):75-83. PubMed ID: 2450260 [TBL] [Abstract][Full Text] [Related]
15. Effects of canrenone on blood pressure in rats with reduced renal mass. Pamnani MB; Whitehorn WV; Clough DL; Haddy FJ Am J Hypertens; 1990 Mar; 3(3):188-95. PubMed ID: 2157466 [TBL] [Abstract][Full Text] [Related]
16. Digoxin-like immunoreactive factor in rat plasma: effect of sodium and calcium intake. Doris PA Life Sci; 1988; 42(7):783-90. PubMed ID: 2828804 [TBL] [Abstract][Full Text] [Related]
17. Facilitatory effects of ouabain and digitalis-like substance on adrenergic transmission in hypertension. Tsuda K; Tsuda S; Shima H; Masuyama Y Am J Hypertens; 1989 Jun; 2(6 Pt 1):465-7. PubMed ID: 2547398 [TBL] [Abstract][Full Text] [Related]
18. Role of ouabainlike compound in rats with reduced renal mass-saline hypertension. Yamada K; Goto A; Hui C; Yagi N; Nagoshi H; Sasabe M; Sugimoto T Am J Physiol; 1994 Apr; 266(4 Pt 2):H1357-62. PubMed ID: 8184913 [TBL] [Abstract][Full Text] [Related]
19. Regression of renal hypertrophy and elevated renal Na+,K+-ATPase activity after insulin treatment in streptozotocin-diabetic rats. Ku DD; Roberts RB; Sellers BM; Meezan E Endocrinology; 1987 May; 120(5):2166-73. PubMed ID: 3032576 [TBL] [Abstract][Full Text] [Related]
20. Digitalis-like factor and digoxin-like immunoreactive factor in diabetic women with preeclampsia, transient hypertension of pregnancy, and normotensive pregnancy. Graves SW; Lincoln K; Cook SL; Seely EW Am J Hypertens; 1995 Jan; 8(1):5-11. PubMed ID: 7734097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]